{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:44:27Z","timestamp":1789685067246,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejca.2023.112949","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T12:25:50Z","timestamp":1687263950000},"page":"112949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study"],"prefix":"10.1016","volume":"190","author":[{"given":"Sophie J.M.","family":"Reijers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4211-9849","authenticated-orcid":false,"given":"Emma","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Gr\u00fcnhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-424X","authenticated-orcid":false,"given":"Marco","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Honore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rastrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Vassos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"Podleska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-7201","authenticated-orcid":false,"given":"Maya","family":"Niethard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andraz","family":"Perhavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Stas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Boecxstaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0579-1193","authenticated-orcid":false,"given":"Hayden","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador Mart\u00edn","family":"Algarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector Martinez","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-2896","authenticated-orcid":false,"given":"Dorian Yarih","family":"Garcia-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Djafarrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-7319","authenticated-orcid":false,"given":"Giorgia","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-3534","authenticated-orcid":false,"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-3003","authenticated-orcid":false,"given":"Maurice","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hohenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winan J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2023.112949_bib1","series-title":"Soft Tissue and Bone Tumours","author":"Board WCoTE","year":"2020"},{"key":"10.1016\/j.ejca.2023.112949_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","article-title":"Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit","volume":"148","author":"Creech","year":"1958","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2023.112949_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejca.2014.11.020","article-title":"Treatment modifications in tumour necrosis factor-alpha (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas","volume":"51","author":"Deroose","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.112949_bib4","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1245\/s10434-009-0733-9","article-title":"Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient","volume":"16","author":"Bonvalot","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib5","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.21802","article-title":"Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma","volume":"106","author":"Grunhagen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.112949_bib6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1245\/s10434-011-2196-z","article-title":"Long-term outcome of isolated limb perfusion in advanced soft tissue sarcoma of the extremity","volume":"19","author":"Olofsson","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2023.112949_bib7","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1245\/s10434-015-4856-x","article-title":"Isolated limb perfusion with melphalan and tumour necrosis factor alpha for in-transit melanoma and soft tissue sarcoma","volume":"22","author":"Smith","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ejso.2020.04.012","article-title":"Isolated limb perfusion is an effective treatment modality for locally advanced Kaposi sarcoma of the extremities","volume":"46","author":"Boere","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2017.07.023","article-title":"Isolated limb perfusion for locally advanced angiosarcoma in extremities: a multi-centre study","volume":"85","author":"Huis In 't Veld","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.112949_bib10","unstructured":"Castor EDC. (2019). Castor Electronic Data Capture. [online] Available at: https:\/\/castoredc.com."},{"key":"10.1016\/j.ejca.2023.112949_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102058","article-title":"Isolated limb perfusion for soft tissue sarcoma: current practices and future directions. A survey of experts and a review of literature","volume":"88","author":"Martin-Tellez","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2023.112949_bib12","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/cncr.29991","article-title":"Role of isolated limb perfusion with recombinant human tumor necrosis factor alpha and melphalan in locally advanced extremity soft tissue sarcoma","volume":"122","author":"Jakob","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.112949_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.112949_bib15","series-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"Organization","year":"1979"},{"key":"10.1016\/j.ejca.2023.112949_bib16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s12094-019-02034-w","article-title":"Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience","volume":"21","author":"Assi","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdi229","article-title":"Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?","volume":"16","author":"Bonvalot","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib18","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1200\/JCO.2011.35.6618","article-title":"Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas","volume":"29","author":"Deroose","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jso.22121","article-title":"Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients","volume":"105","author":"Deroose","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1245\/ASO.2005.03.059","article-title":"Isolated limb perfusion with tumor necrosis factor and melphalan prevents amputation in patients with multiple sarcomas in arm or leg","volume":"12","author":"Grunhagen","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1245\/s10434-006-9040-x","article-title":"Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma","volume":"14","author":"Hayes","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jso.21885","article-title":"TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome","volume":"103","author":"Hoven-Gondrie","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.11648","article-title":"Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities","volume":"98","author":"Noorda","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.112949_bib24","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/cncr.25850","article-title":"Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials","volume":"117","author":"Wray","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.112949_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejso.2005.07.003","article-title":"TNF dose reduction in isolated limb perfusion","volume":"31","author":"Grunhagen","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib26","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1245\/s10434-017-6109-7","article-title":"Isolated limb perfusion and infusion for extremity soft tissue sarcoma: a contemporary systematic review and meta-analysis","volume":"24","author":"Neuwirth","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejso.2016.09.021","article-title":"Isolated limb perfusion for the management limb threatening soft tissue sarcomas: the role of histological type on clinical outcomes","volume":"43","author":"Rastrelli","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00043426-200311000-00016","article-title":"Isolated limb perfusion with rhTNF-alpha and melphalan for locally recurrent childhood synovial sarcoma of the limb","volume":"25","author":"Hohenberger","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1477-7819-11-185","article-title":"The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-alpha: a comparison with the whole group of resected soft tissue sarcomas","volume":"11","author":"Schwindenhammer","year":"2013","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1245\/s10434-013-3247-4","article-title":"Epithelioid sarcoma: need for a multimodal approach to maximize the chances of curative conservative treatment","volume":"21","author":"Levy","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ejso.2005.07.002","article-title":"TNF-based isolated limb perfusion in unresectable extremity desmoid tumours","volume":"31","author":"Grunhagen","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.112949_bib32","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/bjs.9659","article-title":"Isolated limb perfusion using tumour necrosis factor alpha and melphalan in patients with advanced aggressive fibromatosis","volume":"101","author":"van Broekhoven","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2023.112949_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejso.2021.08.007","article-title":"Health-related quality of life after isolated limb perfusion compared to extended resection, or amputation for locally advanced extremity sarcoma: Is a limb salvage strategy worth the effort?","volume":"48","author":"Reijers","year":"2022","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:42:20Z","timestamp":1760733740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923003015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"alternative-id":["S0959804923003015"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.112949","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.112949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112949"}}